NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Efficacy, Satisfaction, and Safety of the Mesolipo® Protocol for the Treatment of Localized Adiposity

CompletedNA

Sponsor: Antony de Paula Barbosa

Conditions: Localized Adiposity

Interventions: Mesolipo®, Pentoxifylline

Countries: Brazil

This randomized, split-body clinical trial aims to evaluate the efficacy, safety, and participant satisfaction of the Mesolipo® protocol for the treatment of localized adiposity. Participants will receive the Mesolipo® intervention on one side of the body and an active comparator on the contralateral side. Outcomes will be assessed through standardized clinical, photographic, ultrasonographic, and patient-reported measures over a 90-day follow-up period to determine treatment effectiveness and safety.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Adults aged 18 years or older.
* Presence of localized adiposity suitable for treatment with the Mesolipo® protocol.
* Willingness and ability to provide written informed consent.
* Ability to comply with all study procedures and follow-up visits.
* Stable body weight for at least 3 months before enrollment.
* Agreement to maintain usual diet and physical activity habits throughout the study.

Exclusion Criteria:

* Pregnancy or breastfeeding.
* Known hypersensitivity to sodium deoxycholate or any study product component.
* Active infection or inflammatory skin disease at the treatment site.
* Previous aesthetic treatment in the target area within the period defined by the protocol.
* Severe systemic disease or any condition that, in the investigator's opinion, could interfere with study participation or outcome assessment.
* Participation in another clinical trial within the previous 30 days.
* Inability or unwillingness to comply with study procedures.

Locations (1)

Belo Horizonte, Minas Gerais, Brazil